BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 7960976)

  • 21. Radiation tolerance of the optic pathway in patients treated with proton and photon radiotherapy.
    Li PC; Liebsch NJ; Niemierko A; Giantsoudi D; Lessell S; Fullerton BC; Adams J; Shih HA
    Radiother Oncol; 2019 Feb; 131():112-119. PubMed ID: 30773177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial cell loss in irradiated optic nerves.
    Levin LA; Gragoudas ES; Lessell S
    Ophthalmology; 2000 Feb; 107(2):370-4. PubMed ID: 10690841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Friendly fire: neurogenic visual loss from radiation therapy.
    Lessell S
    J Neuroophthalmol; 2004 Sep; 24(3):243-50. PubMed ID: 15348995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation-induced bilateral optic neuropathy in cancer of the nasopharynx. Case failure analysis and a review of the literature.
    Wijers OB; Levendag PC; Luyten GP; Bakker BA; Freling NJ; Klesman-Bradley J; Woudstra E
    Strahlenther Onkol; 1999 Jan; 175(1):21-7. PubMed ID: 9951514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late retinal complications of radiation therapy for nasal and paranasal malignancies: relationship between irradiated-dose area and severity.
    Takeda A; Shigematsu N; Suzuki S; Fujii M; Kawata T; Kawaguchi O; Uno T; Takano H; Kubo A; Ito H
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):599-605. PubMed ID: 10348290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural history of radiation papillopathy after proton beam irradiation of parapapillary melanoma.
    Kim IK; Lane AM; Egan KM; Munzenrider J; Gragoudas ES
    Ophthalmology; 2010 Aug; 117(8):1617-22. PubMed ID: 20363507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve tolerance.
    Shrieve DC; Hazard L; Boucher K; Jensen RL
    J Neurosurg; 2004 Nov; 101 Suppl 3():390-5. PubMed ID: 15537194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
    Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed optic nerve complications after proton beam irradiation.
    Chacko JG; Schatz NJ; Glaser JS
    Ann Ophthalmol (Skokie); 2008; 40(3-4):166-70. PubMed ID: 19230355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular complications of high-dose radiotherapy.
    Brady LW
    Oncology (Williston Park); 1996 Jul; 10(7):981-2, 984. PubMed ID: 8837116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
    Puusaari I; Heikkonen J; Kivelä T
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressive visual failure in acromegaly following external pituitary irradiation.
    Atkinson AB; Allen IV; Gordon DS; Hadden DR; Maguire CJ; Trimble ER; Lyons AR
    Clin Endocrinol (Oxf); 1979 May; 10(5):469-79. PubMed ID: 113142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation-induced injury to the visual pathway.
    Jiang GL; Tucker SL; Guttenberger R; Peters LJ; Morrison WH; Garden AS; Ha CS; Ang KK
    Radiother Oncol; 1994 Jan; 30(1):17-25. PubMed ID: 8153376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of dose-response characteristics of four NTCP models using outcomes of radiation-induced optic neuropathy and retinopathy.
    Moiseenko V; Song WY; Mell LK; Bhandare N
    Radiat Oncol; 2011 Jun; 6():61. PubMed ID: 21645390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
    Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton beam therapy of parapapillary choroidal melanoma.
    Riechardt AI; Cordini D; Willerding GD; Georgieva I; Weber A; Seibel I; Lakotka N; Bechrakis NE; Foerster MH; Moser L; Joussen AM
    Am J Ophthalmol; 2014 Jun; 157(6):1258-65. PubMed ID: 24548873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoplasms induced by megavoltage radiation in the head and neck region.
    Steeves RA; Bataini JP
    Cancer; 1981 Apr; 47(7):1770-4. PubMed ID: 6784913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation dose-volume effects of optic nerves and chiasm.
    Mayo C; Martel MK; Marks LB; Flickinger J; Nam J; Kirkpatrick J
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3 Suppl):S28-35. PubMed ID: 20171514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visual Outcomes of Parapapillary Uveal Melanomas Following Proton Beam Therapy.
    Thariat J; Grange JD; Mosci C; Rosier L; Maschi C; Lanza F; Nguyen AM; Jaspart F; Bacin F; Bonnin N; Gaucher D; Sauerwein W; Angellier G; Hérault J; Caujolle JP
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):328-335. PubMed ID: 27084650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catastrophic vision loss from radiation-induced optic neuropathy.
    Aldrees S; Micieli JA
    BMJ Case Rep; 2020 Feb; 13(2):. PubMed ID: 32107259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.